AU2012905406A0 - Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents - Google Patents
Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agentsInfo
- Publication number
- AU2012905406A0 AU2012905406A0 AU2012905406A AU2012905406A AU2012905406A0 AU 2012905406 A0 AU2012905406 A0 AU 2012905406A0 AU 2012905406 A AU2012905406 A AU 2012905406A AU 2012905406 A AU2012905406 A AU 2012905406A AU 2012905406 A0 AU2012905406 A0 AU 2012905406A0
- Authority
- AU
- Australia
- Prior art keywords
- sublingual
- therapeutic agents
- buccal delivery
- tocotrienol derivatives
- tocotrienol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003814 drug Substances 0.000 title 1
- 150000003612 tocotrienol derivatives Chemical class 0.000 title 1
Priority Applications (27)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL13854440T PL2919777T3 (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
JP2015540965A JP6460998B2 (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
BR112015010703-6A BR112015010703B1 (en) | 2012-11-13 | 2013-11-13 | use of a pharmaceutical composition and pharmaceutical composition |
EP13854440.8A EP2919777B1 (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
ES13854440T ES2778065T3 (en) | 2012-11-13 | 2013-11-13 | Transmucosal administration of tocotrienol |
CA2891164A CA2891164C (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
SG11201503640WA SG11201503640WA (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
KR1020147022626A KR20150082109A (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
CN201380022566.8A CN104582700B (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienols |
DK13854440.8T DK2919777T3 (en) | 2012-11-13 | 2013-11-13 | TRANSMUKOSAL RELEASE OF TOCOTRIENOL |
US14/435,607 US10675265B2 (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
MYPI2015000856A MY177940A (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
PCT/AU2013/001310 WO2014075135A1 (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
RU2015120181A RU2015120181A (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
NZ628963A NZ628963A (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
PT138544408T PT2919777T (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
CN202011457257.1A CN112451518A (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienols |
PE2015000622A PE20151518A1 (en) | 2012-11-13 | 2013-11-13 | TRANSMUCOSE ADMINISTRATION OF TOCOTRIENOL |
AU2013344817A AU2013344817B2 (en) | 2012-11-13 | 2013-11-13 | Transmucosal delivery of tocotrienol |
IL238727A IL238727A0 (en) | 2012-11-13 | 2015-05-10 | Transmucosal delivery of tocotrienol |
IN4006DEN2015 IN2015DN04006A (en) | 2012-11-13 | 2015-05-11 | |
PH12015501048A PH12015501048A1 (en) | 2012-11-13 | 2015-05-11 | Transmucosal delivery of tocotrienol |
ZA2015/04191A ZA201504191B (en) | 2012-11-13 | 2015-06-10 | Transmucosal delivery of tocotrienol |
HK15107895.4A HK1207295A1 (en) | 2012-11-13 | 2015-08-14 | Transmucosal delivery of tocotrienol |
JP2018177662A JP6978392B2 (en) | 2012-11-13 | 2018-09-21 | Transmucosal delivery of tocotrienols |
US15/929,297 US11331302B2 (en) | 2012-11-13 | 2020-04-23 | Transmucosal delivery of tocotrienol |
JP2020171008A JP2021008509A (en) | 2012-11-13 | 2020-10-09 | Transmucosal delivery of tocotrienol |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2012905406A0 true AU2012905406A0 (en) | 2013-01-10 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2890780B8 (en) | Methods and compositions for treatment of a genetic condition | |
IL237581B (en) | Derivatives of 6-oxo-pyrazinopyrrolopyrimidines | |
HK1186737A1 (en) | Derivatives of azaindazole or diazaindazole type as medicament | |
ZA201204959B (en) | Pyrazole derivatives as jak inhibitors | |
IL229963A (en) | Substituted quinolines and their use as medicaments | |
FI3156056T3 (en) | Pharmaceutical compositions comprising sorbitan esters | |
HK1207295A1 (en) | Transmucosal delivery of tocotrienol | |
SG10201505752QA (en) | Use of proanthocyanidin b2 for preparing medicaments | |
HK1214523A1 (en) | Transmucosal delivery of glatiramer acetate | |
HK1188791A1 (en) | Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these | |
HK1214522A1 (en) | Oral transmucosal delivery of glatiramer acetate | |
AU2012905406A0 (en) | Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents | |
AU2012904937A0 (en) | Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents | |
AU2012903646A0 (en) | Therapeutic methods and compositions | |
AU2012901350A0 (en) | Therapeutic methods and compositions | |
AU2011903938A0 (en) | Therapeutic methods and compositions | |
GB201108673D0 (en) | Colour stability of dual medicament dressings | |
EP2785722A4 (en) | Tocotrienol derivatives and associated methods | |
AU2011901447A0 (en) | Prophylactic and therapeutic compositions | |
AU2011900644A0 (en) | Therapeutic Uses of SLIRP | |
AU2012903850A0 (en) | Use of enantiomers of perhexiline | |
AU2011900519A0 (en) | Drug compositions for the treatment of insomnia |